By Deron Hamel Epilepsy Ontario’s weekly column, the Voices of Epilepsy, saw strong readership in 2015, and of all the issues covered this year one received more buzz on the organization’s social-media platforms than any other: cannabidiol (CBD). CBD is a substance derived from the marijuana plant. It is the most abundant, non-psychoactive chemical compound…
By Deron Hamel A 2,000-per-cent price hike on a medication to treat infantile spasms is “predatory behaviour” on the part of Questcor Pharmaceuticals, and drug companies could hike prices on other seizure medications if policies aren’t put into place, says pediatric neurologist Dr. Carter Snead. Infantile spasms – also called West syndrome – is a…
By Deron Hamel This week’s edition of Voices of Epilepsy looks at some of the common myths about seizure disorders and helps set the record straight on everything from how to react when a person is having a seizure to how epilepsy affects a person’s ability to hold a driver’s licence. One of the most…
By Deron Hamel A World Health Organization (WHO) resolution that was unanimously passed earlier this year could create large-scale, positive change in epilepsy treatment across the globe, says Mary Secco, an Ontario advocate for people with epilepsy. Secco, who is co-chair of the International League Against Epilepsy’s (ILAE’s) Global Outreach Task Force as well as…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
